Connection

Marco Cattaneo to Purinergic P2Y Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Marco Cattaneo has written about Purinergic P2Y Receptor Antagonists.
Marco Cattaneo
Connection Strength
0.969
Purinergic P2Y Receptor Antagonists
  1. Letter by Cattaneo and von Kügelgen Regarding Article, "International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies". Circulation. 2018 05 22; 137(21):2309.
    View in: PubMed
    Score: 0.628
  2. Cigarette smoking reduces platelet reactivity independently of clopidogrel treatment in patients with non-ST elevation acute coronary syndromes. Platelets. 2018 May; 29(3):309-311.
    View in: PubMed
    Score: 0.152
  3. von Willebrand factor and its cleaving protease ADAMTS13 balance in coronary artery vessels: Lessons learned from thrombotic thrombocytopenic purpura. A narrative review. Thromb Res. 2017 Jul; 155:78-85.
    View in: PubMed
    Score: 0.146
  4. Use of PRECISE-DAPT Score and Admission Platelet Count to Predict Mortality Risk in Patients With Acute Coronary Syndrome. Angiology. 2019 Oct; 70(9):867-877.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.